Benzylboronic acid
CAS: 4463-42-7
Rif. 3D-FB146781
| 1g | Prezzo su richiesta | ||
| 2g | Prezzo su richiesta | ||
| 100mg | Prezzo su richiesta | ||
| 250mg | Prezzo su richiesta | ||
| 500mg | Prezzo su richiesta |
Informazioni sul prodotto
- boronic acid, B-(phenylmethyl)-
- Phenylmethylboronic acid
Benzylboronic acid is a drug target for the treatment of type 2 diabetes. It is used to inhibit glucose monitoring in the body and has been shown to be effective in treating type 2 diabetes by inhibiting gluconeogenesis. Benzylboronic acid has been shown to have an inhibitory effect on toll-like receptor 4 (TLR4) and TLR2, which are involved in the inflammatory response, as well as TLR9, which is involved in the activation of B cells. Benzylboronic acid also inhibits bortezomib, an anti-cancer drug that can cause bone marrow suppression. Benzylboronic acid binds to pyridinium derivatives and esters with nucleophilic groups and forms a covalent bond with them through cross-coupling reactions. This process leads to the formation of a new compound that contains a carbonyl group.
Proprietà chimiche
Richiesta tecnica su: 3D-FB146781 Benzylboronic acid
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
